AUSTIN, Texas, April 28, 2017 (GLOBE
NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today it will
host a conference call and live audio webcast on Thursday, May
4, 2017, at 8:30 a.m. Eastern Time, to provide an overview of
its corporate and clinical activities. The call will
encompass developments during the first quarter ended March
31, 2017.
Conference Call Information:
Interested participants and investors may access the conference
call by dialing:
- 1 (844) 249-9385 (U.S.)
- 1 (270) 823-1533
(International)
- Conference ID: 15848733
A live audio webcast will also be
accessible via the Investors section of
the XBiotech website www.xbiotech.com. The webcast
replay will remain available for 90 days.
A telephonic replay of the conference
call can be accessed by dialing 1 (855) 859-2056 (U.S.) or 1 (404)
537-3406, and providing the Conference ID: 15848733. The
telephonic replay will be available for 24 hours beginning at 11:29
p.m. Eastern Time on May 4, 2017.
About XBiotech
XBiotech is a fully integrated
global biosciences company dedicated to pioneering the discovery,
development and commercialization of therapeutic antibodies based
on its True Human(TM) proprietary technology. XBiotech currently is
advancing a robust pipeline of antibody therapies to redefine the
standards of care in oncology, inflammatory conditions and
infectious diseases. Headquartered in Austin, Texas, XBiotech also
is leading the development of innovative biotech manufacturing
technologies designed to more rapidly, cost-effectively and
flexibly produce new therapies urgently needed by patients
worldwide.
Cautionary Note on Forward-Looking
Statements
This press release contains
forward-looking statements, including with respect to the proposed
offering of common shares, declarations regarding management's
beliefs and expectations that involve substantial risks and
uncertainties. In some cases, you can identify forward-looking
statements by terminology such as "may," "will," "should," "would,"
"could," "expects," "plans," "contemplate," "anticipates,"
"believes," "estimates," "predicts," "projects," "intend" or
"continue" or the negative of such terms or other comparable
terminology, although not all forward-looking statements contain
these identifying words. Forward-looking statements are subject to
inherent risks and uncertainties in predicting future results and
conditions that could cause the actual results to differ materially
from those projected in these forward-looking statements. These
risks and uncertainties are subject to the disclosures set forth in
the "Risk Factors" section of certain of our SEC filings.
Forward-looking statements are not guarantees of future
performance, and our actual results of operations, financial
condition and liquidity, and the development of the industry in
which we operate, may differ materially from the forward-looking
statements contained in this press release. Any forward-looking
statements that we make in this press release speak only as of the
date of this press release. We assume no obligation to update our
forward-looking statements whether as a result of new information,
future events or otherwise, after the date of this press
release.